Condition (MeSH)
Beckwith-Wiedemann Syndrome
ClinicalTrials.gov lists 10 trials for Beckwith-Wiedemann Syndrome or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
10 of the 10 trials are tagged with Beckwith-Wiedemann Syndrome itself; the rest are tagged with a narrower condition beneath it.
When did Beckwith-Wiedemann Syndrome trials start? (9)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 3
- Not applicable
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2023 | 1 |
| 2021 | 1 |
| 2020 | 1 |
| 2018 | 1 |
| 2017 | 1 |
| 2013 | 1 |
| 2010 | 1 |
| 2009 | 1 |
| 2007 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 10 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Beckwith-Wiedemann Syndrome trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 2 |
| Not applicable | 3 |
| Observational | 4 |
| Expanded access | 1 |
How many Beckwith-Wiedemann Syndrome trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 3 |
| Available | 1 |
| Completed | 3 |
| Unknown status | 3 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Beckwith-Wiedemann Syndrome trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Children's Oncology Group | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
Which drugs are being tested for Beckwith-Wiedemann Syndrome? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Dactinomycin | 1 |
| 18F-DOPA | 1 |
Interventions as named in the registry (4)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Doxorubicine | 1 |
| Clostridium botulinum type A (BoNTA) | 1 |
| Radiation Therapy | 1 |
| Vincristina | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Beckwith-Wiedemann Syndrome trials report? (7)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| 24600-Death NOS | 8 | 1 |
| 40600-Hepatobiliary disorders - Other specify | 4 | 1 |
| 11600-Alanine aminotransferase increased | 1 | 1 |
| 15000-Aspartate aminotransferase increased | 1 | 1 |
| 43100-Hypokalemia | 1 | 1 |
Showing 5 of 7 adverse events.
Which publications cover Beckwith-Wiedemann Syndrome? (6)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
Showing 5 of 6 publications.
Prevalence (18)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Beckwith-Wiedemann syndrome | Prevalence at birth | 1-5 / 10 000 | Italy | Not stated | Exact |
| Beckwith-Wiedemann syndrome | Prevalence at birth | 1-9 / 100 000 | Japan | Not stated | Exact |
| Beckwith-Wiedemann syndrome | Prevalence at birth | 1-9 / 100 000 | Spain | Not stated | Exact |
| Beckwith-Wiedemann syndrome | Prevalence at birth | 1-9 / 100 000 | Europe | Not stated | Exact |
| Beckwith-Wiedemann syndrome | Prevalence at birth | 1-9 / 100 000 | Spain | Not stated | Unspecified |
Showing 5 of 18 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Beckwith-Wiedemann syndrome | 116 | Exact | Orphadata Science knowledge files, Product 1 |
| Beckwith-Wiedemann syndrome | 116 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: sub-conditions in mesh.